Erik Ostrowski
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Erik Ostrowski
Erik Ostrowski is recorded as CFO at Akebia Therapeutics, Inc. (AKBA) and CEO at Tectonic Therapeutic, Inc. (TECX). Akebia Therapeutics, Inc. reported in an 8-K filed June 24, 2024 that Erik Ostrowski was appointed Senior Vice President, Chief Financial Officer, Chief Business Officer, Treasurer and principal financial officer, effective June 24, 2024. Tectonic Therapeutic, Inc. reported in an 8-K filed June 20, 2024 that Erik Ostrowski resigned as President, Interim Chief Executive Officer and Chief Financial Officer (principal executive officer, principal financial officer, effective June 20, 2024. Tectonic Therapeutic, Inc. reported in an 8-K filed May 1, 2023 that Erik Ostrowski was appointed President and Interim Chief Executive Officer, effective May 1, 2023. The proxy statement of Akebia Therapeutics, Inc. reports total compensation of $1,792,361 for Erik Ostrowski in fiscal 2025, including a base salary of $552,919. Disclosed compensation is on record for 7 fiscal years. Erik Ostrowski has spoken on 4 earnings calls across 1 company, most recently for Akebia Therapeutics, Inc. on August 5, 2026.
“On June 24, 2024, Akebia Therapeutics, Inc. (the "Company") announced the appointment of Erik Ostrowski as the Company's Senior Vice President, Chief Financial Officer, Chief Business Officer, Treasurer and principal financial officer, effective June 24, 2024 (the "Effective Date").”
“Immediately prior to the Merger, Erik Ostrowski, Steven Avruch, Azadeh Golipour, Ph.D. and Essra Ridha, M.D., MRCP, FFPM resigned from all of their offices with AVROBIO and all of its subsidiaries, if applicable, including, with respect to Mr. Ostrowski, as AVROBIO's President, Interim Chief Executive Officer and Chief Financial Officer (principal executive officer, principal financial officer and principal accounting officer).”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-05-01–present
-
Current
Start not stated–present
-
Akebia Therapeutics, Inc. (AKBA)
Source not stated
Current -
2019-01-01–2021-04-22
Last confirmed by a filing; no departure on record
-
Start not stated–2024-06-20
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Akebia Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- John Butler CEO, CFO, Board Member
- John P. Butler CEO, Board Member
- Ellen Snow CFO
- David A. Spellman Chief Accounting Officer
- Richard C. Malabre Chief Accounting Officer
- Adrian Adams Board Member
- LeAnne M. Zumwalt Board Member
- Michael Rogers Board Member
- Myles Wolf, M.D., M.M.Sc. Board Member
- Myles Wolf, M.D., M.S.Sc. Board Member
Leadership on record at Tectonic Therapeutic, Inc.
Other people whose current roles at this company are on record from its filings.
- Alise Reicin CEO, Board Member
- Alise Reicin, M.D. CEO, Board Member
- François Nader Chairman, Board Member
- Daniel Lochner CFO
- Christian Cortis COO
- Christian Cortis, Ph.D. COO
- Azadeh Golipour CTO
- Peter McNamara CTO
- Peter McNamara, Ph.D. CTO
- Jessica Chutter Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Akebia Therapeutics, Inc. (AKBA) | Senior Vice President, Chief Financial Officer, Chief Business Officer and Treasurer | $552,919 | $1,792,361 |
| 2024 | Akebia Therapeutics, Inc. (AKBA) | Senior Vice President, Chief Financial Officer, Chief Business Officer and Treasurer | $284,414 | $1,215,122 |
| 2024 | Tectonic Therapeutic, Inc. (TECX) | M.B.A. Former President, Interim Chief Executive Officer, Chief Financial Officer and Treasurer | $254,125 | $1,093,258 |
| 2023 | Tectonic Therapeutic, Inc. (TECX) | M.B.A. Former President, Interim Chief Executive Officer, Chief Financial Officer and Treasurer | $504,400 | $1,590,892 |
| 2022 | Tectonic Therapeutic, Inc. (TECX) | President, Interim Chief Executive Officer, Chief Financial Officer and Treasurer | $460,000 | $1,352,093 |
| 2021 | Tectonic Therapeutic, Inc. (TECX) | President, Interim Chief Executive Officer, Chief Financial Officer and Treasurer | $439,254 | $2,705,607 |
| 2020 | Tectonic Therapeutic, Inc. (TECX) | Chief Financial Officer and Treasurer | $424,400 | $2,010,017 |
| 2019 | Tectonic Therapeutic, Inc. (TECX) | Chief Financial Officer and Treasurer | $412,000 | $2,753,795 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.